STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more
Image Credit: STAT News

STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more

Watchdoq November 11, 2024
GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization

Read Full Article